NCT06270667 Effects of Exercise Training in Survivors of Lymphoma
| NCT ID | NCT06270667 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Norwegian School of Sport Sciences |
| Condition | Lymphoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2024-03-20 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2024-03-20 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effects of aerobic exercise with or without addition of resistance exercise to usual care in individuals treated with anthracyclines for lymphomas and to compare exercise effects to age- and sex-matched individuals with no prior history of malignant diseases.
Eligibility Criteria
Inclusion Criteria Lymphoma participants: * Listed in relevant registers * Confirmed lymphoma diagnosis (i.e., Hodgkin lymphoma and aggressive non-Hodgkin lymphoma) * Completed treatment in the past two to five years without relapse or second cancer * Previous anthracycline treatment with or without mediastinal radiation * No severe cancer-related fatigue (per self-report) Inclusion Criteria Lymphoma participants and non-cancer reference group: * Currently not performing \>75 minutes/week of aerobic exercise * Willing and able to adhere to all study procedures. Exclusion Criteria Lymphoma participants: * Relapse since diagnosis * A history, or current presence, of another diagnosis of invasive cancer of any kind Exclusion Criteria Lymphoma participants and non-cancer reference group: * Presence of any uncontrolled- or recent cardiovascular disease * Has undergone heart surgery * Uses a pacemaker * Pregnancy * Unable to read and understand Swedish (applicable for the Swedish site only) * Unable to read and understand Norwegian (applicable for the Norwegian site) * Any physical or mental health condition restricting adherence to study protocol
Contact & Investigator
Tormod S. Nilsen, PhD
PRINCIPAL INVESTIGATOR
Norwegian School of Sport Sciences
Frequently Asked Questions
Who can join the NCT06270667 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Lymphoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06270667 currently recruiting?
Yes, NCT06270667 is actively recruiting participants. Contact the research team at tormodsn@nih.no for enrollment information.
Where is the NCT06270667 trial being conducted?
This trial is being conducted at Oslo, Norway, Uppsala, Sweden.
Who is sponsoring the NCT06270667 clinical trial?
NCT06270667 is sponsored by Norwegian School of Sport Sciences. The principal investigator is Tormod S. Nilsen, PhD at Norwegian School of Sport Sciences. The trial plans to enroll 280 participants.